Understanding sarcoma tumors to find new treatment options
Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities
This study is looking at soft-tissue sarcomas, which are tricky tumors that affect many people, by using mice to understand how these tumors behave and respond to treatments, with the hope of finding better ways to help patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11234139 on NIH RePORTER |
What this research studies
This research investigates soft-tissue sarcomas, which are complex tumors affecting many individuals worldwide. By creating mouse models that mimic the genetic changes found in human sarcoma patients, the study aims to explore how these tumors interact with their surrounding environment and respond to treatments. The research employs advanced techniques like single-cell RNA sequencing to uncover potential new biomarkers and vulnerabilities in these tumors, which could lead to more effective therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with soft-tissue sarcomas, particularly those with aggressive sub-types.
Not a fit: Patients with sarcomas that do not exhibit complex genetic alterations or those who are not eligible for experimental therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new treatment options and improve survival rates for patients with sarcoma.
How similar studies have performed: Other research has shown promise in using animal models to study sarcomas, but this specific approach is innovative and aims to address existing gaps in knowledge.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Guarnerio, Jlenia — University of Tx Md Anderson Can Ctr
- Study coordinator: Guarnerio, Jlenia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.